Maximilian Vargas, PhD MBA, is a Senior Director, US Access Strategy and Account Management within Certara’s Evidence and Access Group since 2012. He brings both scientific training and experience in healthcare product development that are important for evidence-based value and access strategies for pipeline and marketed products.
Leading a team of analysts and focusing on projects involving late stage, launch, and due diligence efforts, Max’ experience cuts across all major therapeutic areas and care settings with special emphasis on CV / metabolics, oncology, gene therapies, ophthalmology, GI, and dermatology. Max and team have designed successful pricing and contracting strategies for products at launch and throughout the life cycle. He also leads projects focusing on managed markets communications strategies.
In his prior work, Max served as a subject matter expert for the CT Center for Entrepreneurship and Innovation where he led teams that developed comprehensive strategic plans for early stage life science companies.
After graduating from Wesleyan University, Max completed his PhD in Biochemistry and Molecular Biology at the University of Connecticut Health Center, where his work helped define a novel clinical target preventing the expression of genes involved in the development of heart disease. Max complemented his scientific education with an MBA focused on Healthcare Policy and Management from the University of Connecticut.